Talk TitleSpeakerAbstract Duration
Nucleic acid biomarkers:Optimizing strategies from discovery to utilizationDr. Steven JacksonBiomarkers, also known as molecular markers or signature molecules, are important for drug development and translational research.  In this webinar, we define and discuss the various types of biomarkers.  We show how biologics discovery and development researchers are identifying and utilizing nucleic acid biomarkers.  We will present some novel AI-driven tools to facilitate assisting oncology biomarker research.  Finally, we give examples of how various genetic analysis tools fit together in biomarker workflows. 20 minutes
Real-time PCR for MRD assessment in common hematological malignanciesDr. Teerapong Siriboonpiputtana 
Measurable residual disease detection on cancer-specific genetic biomarkers is essential for effectively managing common subtypes of blood cancers. Herein, we empower highly specific RT-qPCR for quantitative analysis of BCR::ABL1 level during TKIs therapy in CML and extended use of RQ-PCR technology for MRD assessment in common hematological malignancies. 
20 minutes

For Research Use Only. Not for use in diagnostic procedures.
© 2024 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified
View our Privacy Policy .